ArticleBMC gastroenterology2026
Low seroprevalence of hepatitis B virus and absence of hepatitis C virus among patients attending dental clinics in Mogadishu, Somalia.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) and hepatitis C virus (HCV) represent major global health challenges, especially in areas where healthcare resources are restricted. This study estimated the seroprevalence of HBV and HCV among patients visiting a selected dental clinic in Mogadishu, Somalia.
methodsThis cross-sectional study was carried out in Alfurad Dental Clinic between February 2023 and March 2024. A sample size of 410 participants was calculated using Cochran’s formula. Data was collected using structured interviews along with serological testing for hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV). Statistical analyses were conducted using SPSS (version 27.0), with a significance level set at p < 0.05.
resultsAmong the 410 participants, the seroprevalence of HBV was 2.0% (95% CI: 0.9% to 3.6%), with no cases of HCV reported. The majority of participants were female (73.7%). The highest prevalence of HBV was observed in the 60–69 years old age group, and 45.9% of participants had non-formal education. The proportion of individuals vaccinated against hepatitis B was low, at 3.2%, and none of them were found to be infected. No statistically significant associations were identified between HBV prevalence and the following demographic variables: age, gender, marital status, and educational level, or medical history (p > 0.05).
conclusionsThe present study reveals a low prevalence of HBV among dental patients in Mogadishu, with a seroprevalence of 2.0%. There were no reported cases of HCV. The results highlight the importance of improved public health strategies that prioritize screening and vaccination to reduce the risk of hepatitis transmission within this particular population. Further investigation is crucial to track developments and guide specific actions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.